Advertisement

Medical Management of Acute Pancreatitis

  • Marco Romiti
  • Luciano Minestroni
  • Walter Siquini
  • Gabriele Corradini
Part of the Updates in Surgery book series (UPDATESSURG)

Abstract

All cases of mild acute pancreatitis (AP) and the majority of the severe forms of the disease are treated conservatively. Medical therapy is therefore of fundamental importance in the management of this disease. However, apart from the common devices of cardiovascular and respiratory support, thanks to which the early mortality in severe AP has been greatly reduced, to this day we do not have a specific and effective drug capable of acting on the physiopathology of the disease and of leading to a positive outcome. Antibiotic prophylaxis, equally a cornerstone of medical therapy, has for the past few years come under critical scrutiny.

Keywords

Acute Pancreatitis Acute Pancreatitis Antibiotic Prophylaxis Pancreatic Juice Severe Acute Pancreatitis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Feldman M, Friedman LS, Sleisenger MH (2004) Malattie dell’apparato gastrointestinale e del fegato: pancreas-vie biliari. Excerpta Medica, MilanoGoogle Scholar
  2. 2.
    Frossard JL, Steer ML, Pastor CM (2008) Acute pancreatitis. Lancet 371 (9618):143–152CrossRefPubMedGoogle Scholar
  3. 3.
    Sabiston (2003) Trattato di chirurgia: le basi biologiche della moderna pratica chirurgica. (1st italian edn, 16th American edn). Antonio Delfino Editore, RomaGoogle Scholar
  4. 4.
    Chipman JG (2005) Acute pancreatitis in the surgical intensive care unit. In: Abrams JH, Druck P, Cerra FB (eds) Surgical critical care, 2nd edn. Taylor & Francis, LondonGoogle Scholar
  5. 5.
    Hayden P, Wyncoll D (2008) Severe acute pancreatitis. Curr Anaesth Crit Care 19:1CrossRefGoogle Scholar
  6. 6.
    Whang EE (2006) Acute pancreatitis. In: Mulholland MW, Lillemoe KD, Doherty GM et al (eds) Greenfield’s surgery: Scientific principles and practice, 4th edn. Lippincott Williams & Wilkins, PhiladelphiaGoogle Scholar
  7. 7.
    Caronna R, Diana L, Nofroni I et al (2005) Effects of gabexate mesilate (FOY) on amylase and phospholipase A2 in human serum and pancreatic juice. Dig Dis Sci 50:868–873CrossRefPubMedGoogle Scholar
  8. 8.
    Uhl W, Büchler MW, Malfertheiner P et al (1999) A randomized, double blind, multicentre trial of octreotide in moderate to severe acute pancreatitis. Gut 45:97–104PubMedCrossRefGoogle Scholar
  9. 9.
    Heinrich S, Schäfer M, Rousson V, Clavien PA (2006) Evidence-based treatment of acute pancreatitis. A look at established paradigms. Ann Surg 243:154–168CrossRefPubMedGoogle Scholar
  10. 10.
    Paran H, Mayo A, Paran D et al (2000) Octreotide treatment in patients with severe acute pancreatitis. Dig Dis Sci 45:2247–2251CrossRefPubMedGoogle Scholar
  11. 11.
    Andriulli A, Leandro G, Clemente R et al (1998) Meta-analysis of somatostatin, octreotide and gabexate mesilate in the therapy of acute pancreatitis. Aliment Pharmacol Ther 12:237–245CrossRefPubMedGoogle Scholar
  12. 12.
    Pederzoli P, Cavallini G, Falconi M, Bassi C (1993) Gabexate mesilate vs aprotinin in human acute pancreatitis (GA.ME.P.A.). A prospective, randomized, double blind, multicentre study. Int J Pancreatol 14:117–124PubMedGoogle Scholar
  13. 13.
    Chen HM, Chen JC, Hwang TL et al (2000) Prospective and randomized study of gabexate mesilate for the treatment of severe acute pancreatitis with organ dysfunction. Hepatogastroenterology 47:1147–1150PubMedGoogle Scholar
  14. 14.
    Pezzilli R, Miglioli M (2001) Multicentre comparative study of two schedules of gabexate mesilate treatment of acute pancreatitis. Italian Acute Pancreatitis Study Group. Dig Liver Dis 33:49–57Google Scholar
  15. 15.
    Messori A, Rampazzo R, Scroccaro G et al (1995) Effectiveness of gabexate mesilate in acute pancreatitis. A meta-analysis. Dig Dis Sci 40:734–738CrossRefPubMedGoogle Scholar
  16. 16.
    Banfi R, Borselli G, Cappelletti S et al (2005) Gabexate mesilate and acute pancreatitis: an experience of evidence based drug information for improving rational drug use. Pharm World Sci 27:121–123CrossRefPubMedGoogle Scholar
  17. 17.
    Nathens AB, Curtis JR, Beale RJ et al (2004) Management of the critically ill patient with severe acute pancreatitis. Crit Care Med 32:2524–2535CrossRefPubMedGoogle Scholar
  18. 18.
    Schein M (2005) Acute pancreatitis. In: Schein’s common sense emergency abdominal surgery. Springer, Berlin Heidelberg New YorkCrossRefGoogle Scholar
  19. 19.
    Sanio V, Kemppainen E, Puolakkainen P et al (1995) Early antibiotic treatment in acute necrotizing pancreatitis. Lancet 346:663–667CrossRefGoogle Scholar
  20. 20.
    Delcensire R, Yzet T, Ducroix JP et al (1996) Prophylactic antibiotics in treatment of severe acute alcoholic pancreatitis. Pancreas 13:198–201Google Scholar
  21. 21.
    Shwarz M, Isenmann R, Meyer H et al (1997) Antibiotic use in necrotizing pancreatitis: results of a controlled study. Dtsh Med Wochenschr 122:356–361CrossRefGoogle Scholar
  22. 22.
    Pederzoli P, Bassi S, Vesentini S et al (1993) A randomized multicenter clinical trial of antibiotic prophylaxis of septic complications in acute necrotizing pancreatitis with imipenem. Surg Gynecol Obstet 176:480–483PubMedGoogle Scholar
  23. 23.
    Nordback I, Sand J, Saaristo R et al (2001) Early treatment with antibiotics reduces the need for surgery in acute necrotizing pancreatitis: a single-center randomized study. J Gastrointest Surg 5:113–119CrossRefPubMedGoogle Scholar
  24. 24.
    Bassi C, Falconi M, Talamini G et al (1998) A controlled clinical trial of pefloxacin versus imipenem in severe acute pancreatitis. Gastroenterology 115:1513–1517CrossRefPubMedGoogle Scholar
  25. 25.
    Manes G, Rabitti PG, Menchise A et al (2003) Prophylaxis with meropenem of septic complications in acute pancreatitis: a randomized, controlled trial versus imipenem. Pancreas 27:79–83CrossRefGoogle Scholar
  26. 26.
    Manes G, Uomo I, Menchise A et al (2006) Timing of antibiotic prophylaxis in acute pancreatitis: a controlled randomized study with meropenem. Am J Gastroenterol 101:1348–1353CrossRefPubMedGoogle Scholar
  27. 27.
    Golub R, Siddiqi F, Pohl D (1998) Role of antibiotics in acute pancreatitis: a meta-analysis. J Gastrointest Surg 2:496–503CrossRefPubMedGoogle Scholar
  28. 28.
    Bassi C, Larvin M, Villatoro E (2003) Antibiotic therapy for prophylaxis against infection of pancreatic necrosis in acute pancreatitis. Cochrane Database Syst Rev 4:CD002941PubMedGoogle Scholar
  29. 29.
    Sharma VK, Howden CW (2001) Prophylactic antibiotic administration reduces sepsis and mortality in acute necrotizing pancreatitis: a meta-analysis. Pancreas 22:28–31CrossRefPubMedGoogle Scholar
  30. 30.
    Zhou YM, Xue ZL, Li Ym et al (2005) Antibiotic prophylaxis in patients with severe acute pancreatitis. Hepatobiliary Pancreat Dis Int 4:23–27PubMedGoogle Scholar
  31. 31.
    Villatoro E, Bassi C, Larvin M (2006) Antibiotic therapy for prophylaxis against infection of pancreatic necrosis in acute pancreatitis. Cochrane Database Syst Rev 4:CD002941PubMedGoogle Scholar
  32. 32.
    Isenmann R, Runzi M, Kron M (2004) Prophylactic antibiotic treatment in patients with predicted severe acute pancreatitis: a placebo-controlled, double blind trial. Gastroenterology 126:997–1004CrossRefPubMedGoogle Scholar
  33. 33.
    Dellinger EP, Tellado JM, Soto NE et al (2007) Early antibiotic treatment for severe acute necrotizing pancreatitis: a randomized, double blind, placebocontrolled study. Ann Surg 245:674–683CrossRefPubMedGoogle Scholar
  34. 34.
    Luiten EJT, Hop WCJ, Lange JF et al (1995) Controlled clinical trial of selective decontamination for the treatment of severe acute pancreatitis. Ann Surg 222:57–65CrossRefPubMedGoogle Scholar
  35. 35.
    De Waele JJ, Vogelaers D, Blot S et al (2003) Fungal infections in patients with severe acute pancreatitis and the use of prophylactic therapy. Clin Infect Dis 37:208–213CrossRefPubMedGoogle Scholar
  36. 36.
    Grewe M, Tsiotos GG, Luque de Leon E et al (1999) Fungal infection in acute necrotizing pancreatitis. J Am Coll Surg 188:408–414CrossRefPubMedGoogle Scholar
  37. 37.
    He YM, Lu XS, Ai ZL et al (2003) Prevention and therapy of fungal infection in severe acute pancreatitis: a prospective clinical study. World J Gastroenterol 9:2619–2621PubMedGoogle Scholar

Copyright information

© Springer-Verlag Italia 2009

Authors and Affiliations

  • Marco Romiti
    • 1
  • Luciano Minestroni
    • 1
  • Walter Siquini
    • 2
  • Gabriele Corradini
    • 1
  1. 1.Division of General SurgeryA. Murri HospitalFermo (AP)Italy
  2. 2.Department of Surgery, Ospedali Riuniti University HospitalPolytechnic University of MarcheAnconaItaly

Personalised recommendations